Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD
Clinical trial NCT03256552 · COMPLETED
Trial details
- NCT number
- NCT03256552
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-28
- Primary completion
- 2015-09-05
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.